Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012 (2012), Article ID 691089, 7 pages
http://dx.doi.org/10.1155/2012/691089
Review Article

Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques

1MRC/Centre for Inflammation Research, QMRI, University of Edinburgh, Edinburgh EH16 4TJ, UK
2Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham NG7 2RD, UK

Received 16 February 2012; Accepted 22 March 2012

Academic Editor: Guruprasad P. Aithal

Copyright © 2012 V. K. Snowdon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Robert W. Elder, Nancy M. McCabe, Camden Hebson, Emir Veledar, Rene Romero, Ryan M. Ford, William T. Mahle, Brian E. Kogon, Anurag Sahu, Maan Jokhadar, Michael E. McConnell, and Wendy M. Book, “Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study,” International Journal of Cardiology, 2013. View at Publisher · View at Google Scholar
  • Dao-Bing Zeng, Chuan-Zhou Dai, Shi-Chun Lu, Ning He, Wei Wang, and Hong-Jun Li, “Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension,” World Journal Of Gastroenterology, vol. 19, no. 8, pp. 1292–1298, 2013. View at Publisher · View at Google Scholar
  • D. J. Leeming, M. A. Karsdal, I. Byrjalsen, F. Bendtsen, J. Trebicka, M. J. Nielsen, C. Christiansen, S. Moller, and A. Krag, “Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension,” Alimentary Pharmacology & Therapeutics, vol. 38, no. 9, pp. 1086–1096, 2013. View at Publisher · View at Google Scholar
  • Sara Manti, Lucia Marseglia, Gabriella D Angelo, Martina Filippelli, Caterina Cuppari, Eloisa Gitto, Claudio Romano, Teresa Arrigo, and Carmelo Salpietro, “Portal Hypertension as Immune Mediate Disease,” Hepatitis Monthly, vol. 14, no. 5, 2014. View at Publisher · View at Google Scholar
  • Diana J. Leeming, Sanne S. Veidal, Morten A. Karsdal, Mette Juul Nielsen, Jonel Trebicka, Troels Busk, Flemming Bendtsen, Aleksander Krag, and Søren Møller, “Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis,” Scandinavian Journal of Gastroenterology, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Hugo Perazzo, Valdilea G. Veloso, Beatriz Grinsztejn, Chris Hyde, and Rodolfo Castro, “Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography,” International Journal of Hepatology, vol. 2015, pp. 1–5, 2015. View at Publisher · View at Google Scholar
  • Mindaugas Marozas, Romanas Zykus, Andrius Sakalauskas, Limas Kupčinskas, and Arūnas Lukoševičius, “Noninvasive Evaluation of Portal Hypertension Using a Supervised Learning Technique,” Journal of Healthcare Engineering, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar